We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWRD icon
1401
Forward Air
FWRD
$654M
$5.08M 0.01%
80,809
+3,860
+5% +$260K
VCEL icon
1402
Vericel Corp
VCEL
$2.31B
$5.08M 0.01%
142,549
-2,675
-2% -$93.2K
AXS icon
1403
AXIS Capital
AXS
$7.55B
$5.07M 0.01%
91,606
+3,197
+4% +$178K
ARCH
1404
DELISTED
Arch Resources, Inc.
ARCH
$5.07M 0.01%
30,563
+277
+0.9% +$43.5K
PCRX icon
1405
Pacira BioSciences
PCRX
$997M
$5.02M 0.01%
148,905
+7,782
+6% +$228K
CACC icon
1406
Credit Acceptance
CACC
$6.08B
$5.02M 0.01%
9,421
-102
-1% -$45.9K
USPH icon
1407
US Physical Therapy
USPH
$1.22B
$5.02M 0.01%
53,859
-123
-0.2% -$10.8K
KAI icon
1408
Kadant
KAI
$3.99B
$5.01M 0.01%
17,873
-76
-0.4% -$19K
STNG icon
1409
Scorpio Tankers
STNG
$3.81B
$4.98M 0.01%
81,956
+949
+1% +$53.4K
NTLA icon
1410
Intellia Therapeutics
NTLA
$1.67B
$4.98M 0.01%
163,358
-627
-0.4% -$18K
LMAT icon
1411
LeMaitre Vascular
LMAT
$1.86B
$4.98M 0.01%
87,673
-2,114
-2% -$111K
BL icon
1412
BlackLine
BL
$1.72B
$4.97M 0.01%
79,597
-1,265
-2% -$71.5K
GSHD icon
1413
Goosehead Insurance
GSHD
$2.32B
$4.96M 0.01%
65,482
-1,919
-3% -$139K
NGVT icon
1414
Ingevity
NGVT
$2.68B
$4.96M 0.01%
105,022
+4,608
+5% +$191K
UPBD icon
1415
Upbound Group
UPBD
$1.16B
$4.95M 0.01%
145,853
-7,830
-5% -$233K
TDW icon
1416
Tidewater
TDW
$4.12B
$4.94M 0.01%
68,557
-514
-0.7% -$33.3K
OXM icon
1417
Oxford Industries
OXM
$552M
$4.94M 0.01%
49,417
-1,465
-3% -$136K
HOPE icon
1418
Hope Bancorp
HOPE
$1.79B
$4.93M 0.01%
407,996
-3,504
-0.9% -$34.8K
CRBG icon
1419
Corebridge Financial
CRBG
$15B
$4.93M 0.01%
227,382
+75,263
+49% +$1.55M
MGPI icon
1420
MGP Ingredients
MGPI
$375M
$4.92M 0.01%
49,947
-80
-0.2% -$7.69K
PBR icon
1421
Petrobras
PBR
$116B
$4.91M 0.01%
307,399
+1,018
+0.3% +$15.6K
MOD icon
1422
Modine Manufacturing
MOD
$10.4B
$4.89M 0.01%
81,957
+772
+1% +$37.8K
EELV icon
1423
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$428M
$4.88M 0.01%
202,937
-463
-0.2% -$10.6K
CPRX
1424
DELISTED
Catalyst Pharmaceutical
CPRX
$4.86M 0.01%
288,921
-3,265
-1% -$44.6K
SVC
1425
Service Properties Trust
SVC
$1.07B
$4.86M 0.01%
113,705
-7,138
-6% -$270K

Similar funds

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.